The monoclonal antibodies market was valued at USD 263.22 billion and is projected to reach USD 719.81 billion, with a CAGR of 13.40% by 2032.

Global Monoclonal Antibodies Market Segmentation, By Production Methods (In Vivo, In Vitro), Source (Murine, Chimeric, Humanized, Human, Others), Indication (Cancer, Autoimmune Diseases, Inflammatory Diseases, Infectious Diseases, Others), Route of Administration (Intravenous, Subcutaneous, Intravitreal, Others), End-Users (Hospitals, Specialty Clinics, Homecare, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others) – Industry Trends and Forecast to 2032